Differential effects of 1,25-dihydroxyvitamin D3 on oral squamous cell carcinomas in vitro

Journal of Dietary Supplements

Volumn 11, Issue 2, 2014, Pages 145-154

  Osafi, Javid ^a   Hejazi, Ali ^a   Stutz, Derek D ^a   Keiserman, Mark A ^b   Bergman, Christine J ^a   Kingsley, Karl ^a  

^a UNIVERSITY OF NEVADA   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

Apoptosis; Oral cancer; Supplementation; Vitamin D

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE; DIHYDROXY-VITAMIN D3; PROTEIN BAX; VITAMIN; VITAMIN D;

ANALOGS AND DERIVATIVES; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; CELL SURVIVAL; COMPARATIVE STUDY; DIET SUPPLEMENTATION; HUMAN; METABOLISM; MOUTH NEOPLASMS; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA, SQUAMOUS CELL; CASPASES; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DIETARY SUPPLEMENTS; HUMANS; MOUTH NEOPLASMS; VITAMIN D; VITAMINS;

EID: 84896946730     PISSN: 19390211     EISSN: 1939022X     Source Type: Journal    
DOI: 10.3109/19390211.2013.859209     Document Type: Article

References (35)

1. Akutsu N, Lin R, Bastien Y, Bestawros A, Enepekides DJ, Black MJ, White JH. Regulation of gene Expression by 1alpha, 25-dihydroxyvitamin D3 and Its analog EB1089 under growthinhibitory conditions in squamous carcinoma Cells. Molecular endocrinology (Baltimore, Md.). 2001;15(7):1127-1139.
2. Bektas-Kayhan K, Unur M, Yaylim-Eraltan I, et al. Association of vitamin D receptor Taq I polymorphism and susceptibility to oral squamous cell carcinoma. In vivo (Athens, Greece). 2010;24(5):755-759.
3. Blot WJ, McLaughlin JK,Winn DM, Austin DF, Greenberg RS, Preston-Martin S, Bernstein L, Schoenberg JB, Stemhagen A, Fraumeni JF Jr. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res. 1998;489:3282-3287.
4. Cadoni G, Boccia S, Petrelli L, et al. A review of genetic epidemiology of head and neck cancer related to polymorphisms in metabolic genes, cell cycle control and alcohol metabolism. Acta Otorhinolaryngol Ital. 2012;32(1):1-11.
5. Chang X, Monitto CL, Demokan S, Kim MS, Chang SS, Zhong X, Califano JA, Sidransky D. Identification of hypermethylated genes associated with cisplatin resistance in human cancers. Cancer Res. 2010;70(7):2870-2879.
6. Chaturvedi AK. Epidemiology and clinical aspects ofHPV in head and neck cancers. Head Neck Pathol. 2012;6 (1):S16-24. Epub 2012 Jul 3.
7. Chen C, Mendez E, Houck J, et al. Gene expression profiling identifies genes predictive of oral squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2008;17(8):2152-2162.
8. Curado MP,Hashibe M.Recent changes in the epidemiology of head and neck cancer. Curr Opin Oncol. 2009;21(3):194-200.
9. Dahler AL, Jones SJ, Dicker AJ, Saunders NA. Keratinocyte growth arrest is associated with activation of a transcriptional repressor element in the human cdk1 promoter. J Cell Physiol. 1998;177(3):474-482.
10. Fleet JC, De Smet M, Johnson R, Li Y. VitaminDand cancer: a review of molecular mechanisms. Biochem J. 2012;441(1):61-76.
11. Garavello W, Lucenteforte E, Bosetti C, La Vecchia C. The role of foods and nutrients on oral and pharyngeal cancer risk. Minerva Stomatol. 2009;58(1-2):25-34.
12. Giovannucci E. Vitamin D status and cancer incidence and mortality. Adv Exp Med Biol. 2008;624:31-42.
13. Ha PK, Chang SS, Glazer CA, Califano JA, Sidransky D. Molecular techniques and genetic alterations in head and neck cancer. Oral Oncol. 2009;45(4-5):335-339.
14. Hama T, Norizoe C, Suga H, et al. Prognostic significance of vitamin D receptor polymorphisms in head and neck squamous cell carcinoma. PLoS ONE. 2011;6(12):e2.
15. Hays WL. Statistics. 5. International Thomson Publishing. Inferences about population means; pp. 311-342, 1994.
16. Heaney RP. Vitamin D-baseline status and effective dose. N Engl J Med. 2012;367(1):77-78.
17. Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Dietary Reference Intakes for Calcium, Phosphorus,Magnesium, VitaminD, and Fluoride.Washington, DC: National Academies Press (US); 1997.
18. King M, Chatelain K, Farris D, Jensen D, Pickup J, Swapp A, O'Malley S, Kingsley K. Oral squamous cell carcinoma proliferative phenotype is modulated by proanthocyanidins: a potential prevention and treatment alternative for oral cancer. BMC Complement Altern Med. 2007;7:22.
19. Krishnan AV, Trump DL, Johnson CS, Feldman D. The role of vitamin D in cancer prevention and treatment. Endocrinol Metab Clin North Am. 2010;39(2):401-418.
20. Kugu K, Ratts VS, Piquette GN, Tilly KI, Tao XJ, Martimbeau S, Aberdeen GW, Krajewski S, Reed JC, Pepe GJ, Albrecht ED, Tilly JL. Analysis of apoptosis and expression of bcl-2 gene family members in the human and baboon ovary. Cell Death Differ. 1998;5(1):67-76.
21. Lin R, Nagai Y, Sladek R, et al. Expression profiling in squamous carcinoma cells reveals pleiotropic effects of vitamin D3 analog EB1089 signaling on cell proliferation, differentiation, and immune system regulation. Molecular endocrinology (Baltimore, Md.). 2002;16(6):1243-1256.
22. Lucenteforte E, Garavello W, Bosetti C, La Vecchia C. Dietary factors and oral and pharyngeal cancer risk. Oral oncology. 2009;45(6):461-467.
23. McCabe J, Hajibandeh J, Tran MD, Meeder CA, Sharma K, Nguyen DH, Moody M, Keiserman MA, Bergman CJ, Kingsley K. Folate supplementation induces differential dose-dependent modulation of proliferative phenotypes among cancerous and non-cancerous oral cell lines in vitro. J Diet Suppl. 2010;7(4):325-340.
24. Qiu W, Schonleben F, Li X, Su GH. Disruption of transforming growth factor beta-Smad signaling pathway in head and neck squamous cell carcinoma as evidenced by mutations of SMAD2 and SMAD4. Cancer Lett. 2007;245(1-2):163-170.
25. Ruiz-Ruiz C, Ruiz de Almodovar C, Rodriguez A, Ortiz-Ferron G, Redondo JM, Lopez-Rivas A. The up-regulation of human caspase-8 by interferon-gamma in breast tumor cells requires the induction and action of the transcription factor interferon regulatory factor-1. J Biol Chem. 2004;279(19):19712-19720.
26. Saman DM. A review of the epidemiology of oral and pharyngeal carcinoma: update.Head Neck Oncol. 2012;4:1.
27. Seki Y, Yamamoto H, Yee Ngan C, Yasui M, Tomita N, Kitani K, Takemasa I, Ikeda M, Sekimoto M, Matsuura N, Albanese C, Kaneda Y, Pestell RG, Monden M. Construction of a novel DNA decoy that inhibits the oncogenic beta-catenin/T-cell factor pathway.Mol Cancer Ther. 2006;5(4):985-994.
28. Shils ME, Shike M. Modern Nutrition In Health And Disease. Lippincott Williams & Wilkins; 2006.
29. Swango PA. Cancers of the oral cavity and pharynx in the United States: an epidemiologic overview. J Public Health Dent. 1996;56:309-318.
30. Timmermann S, Hinds PW, Munger K. Re-expression of endogenous p16ink4a in oral squamous cell carcinoma lines by 5-aza-2'-deoxycytidine treatment induces a senesence-like state. Oncogene. 1998;17(26):3445-3453.
31. Tsai WC, Lin YC, Tsai ST, Shen WH, Chao TL, Lee SL,Wu LW. Lack of modulatory function of coding nucleotodie polymorphism S100A2 185 G? A in oral squamous cell carcinoma. Oral Dis. 2011;17(3):283-290.
32. Vakifahmetoglu H, Olsson M, Orrenius S, Zhivotovsky B. Functional connection between p53 and caspase-2 is essential for apoptosis induced by DNA damage. Oncogene. 2006;25:5683-5692.
33. Yang YY, Woo ES, Reese CE, Bahnson RR, Saijo N, Lazo JS. Human metallothionein isoform gene expression in cisplatin-sensitive and resistant cells. Mol Pharmacol. 1994;45(3):453-460.
34. Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H. meta-analysis: serum vitamin D and breast cancer risk. Eu J Cancer. 2010;46(12):2196-2205.
35. Zeljic K, Supic G, Stamenkovic Radak M, Jovic N, Kozomara R, Magic Z. Vitamin D receptor, CYP27B1 and CYP24A1 genes polymorphisms association with oral cancer risk and survival. J Oral Pathol Med. 2012;41(10):779-787.